Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Dig Dis Sci. 2011 Mar 12;56(9):2553–2565. doi: 10.1007/s10620-011-1651-9

Fig. 6.

Fig. 6

Mesenteric and mucosal distal colon blood flow as measured by laser Doppler perfusion imager. Mesenteric flow was significantly increased in the DSS + placebo group vs. the naive group. Losartan and Candesartan resulted in a decline in mesenteric and mucosal flows compared to the naive group, but use of DCL did not significantly change flow at either site. The scores were compared to the naive cohort for significance. Data (mean ± SD; n = 6 per group) were analyzed using ANOVA